News
Is there a reason to travel outside the US for PRRT?
By Josh Mailman Being a NET patient usually means some amount of travel for our care. While the pandemic has negatively impacted almost every aspect
Faces of Philanthropy: Erica Roberts
Making a Big Impact, One Month at a Time Erica Roberts remembers that her father told her and her brother when they were growing up
NETRF’s 2020 Virtual Research Symposium expanded Attendance and Participation
COVID forced NETRF’s annual Research Symposium to be held as a virtual meeting in November. Despite this change, the Symposium reached more researchers than ever
Delayed NET Diagnosis is a Worldwide Problem
This year’s NET Cancer Day focused on the all-too-common experience of delayed diagnosis and misdiagnosis among those with neuroendocrine tumors. INCA, International Neuroendocrine Cancer Alliance,
Faces of Philanthropy: Steve Kaufer
“We have come a long, long way.” When Steve Kaufer’s wife Caroline was diagnosed with neuroendocrine cancer, he began searching for experts who knew about
Faces of Philanthropy:
The Firsty Family
Since 2009, the Firsty Family has organized the Palo Alto Moonlight Walk in honor of Julie Seltzer Firsty. Read more about how their steps have made a difference.
Earning Her Stripes as a Pink Zebra
By the time she was 40 years old, Alicia Gutierrez had earned her stripes as a pink zebra with diagnoses of breast cancer and pancreatic neuroendocrine cancer.
COVID-19 and NETs: What We Now Know
Oncologist Mark Lewis, MD, discusses what we have learned about COVID-19 and NETs in the first six months of the pandemic in this video interview with NETRF CEO Elyse Gellerman.
Making An Everlasting Impact Tribute
NETRF is shining a light on its Everlasting Impact Tribute program, which helps families make a larger impact on NET research with a dynamic program that honors their loved ones.
New NETWise Podcasts on NET Sites
Beginning in August, the NETWise podcast is putting together primary site-specific episodes. NETs can arise almost anywhere in the body, but most start in the gastrointestinal tract, lung, and pancreas.